Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Recruiting 6Completed 5Not yet recruiting 3Active not recruiting 2Unknown 1No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Waldenstrom Macroglobulinemia 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Multiple Myeloma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Intraocular Lymphoma 1Cardiovascular Diseases 1

Interventions

zanubrutinib 3Rituximab 3Bendamustine Hydrochloride 3ibrutinib 2talquetamab 1pirtobrutinib 1Sra protein, Drosophila 1Specimen Handling 1Sirolimus 1Prednisone 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Everolimus 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Waldenstrom Macroglobulinemia × zanubrutinib × Clear all
NCT07474961 2026-03-16

BLOOD-dose

Rigshospitalet, Denmark

Phase 4 Not yet recruiting
400 enrolled
LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT06547866 2025-11-26

WAZABI

French Innovative Leukemia Organisation

Phase 2 Not yet recruiting
102 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT06942507 2025-04-30

BRZ-WM

Peking Union Medical College Hospital

Phase NA Not yet recruiting
104 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡